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The magnitude of confounding is examined in nine case studies of two “weak” relation- 
ships: between artificial sweeteners and bladder cancer, and between oral contraceptives 
and cervical dysplasia. Confounding had little or no influence on the results of any pub- 
lished study. The responsible epidemiologist must always consider the possibility of con- 
founding, no less when associations are weak than when they are strong. Identification of 
potentially confounding variables is an integral part of good epidemiologic practice. Rarely, 
however, does confounding itself, especially from unidentified sources, live up to its reputa- 
tion for introducing seriously spurious associations. An investigator is more likely to be led 
astray by undetected biases than by pure confounding. o 1987 Academic PXSS. IN 
INTRODUCTION 
Confounding is the phenomenon whereby an association between two study 
variables, usually the exposure and the disease outcome it is thought to cause, is 
over- or underestimated through the agency of a third variable, the confounder. 
Confounding is the cause of great angst among epidemiologists, who go to great 
lengths searching out confounders and exorcising them through elaborate 
schemes. 
While there is no escaping the central importance of confounding, many unnec- 
essary and possibly damaging activities may take place in its name. Controversial 
studies are often criticized by appeal to hypothetical confounding factors, as 
often as not unnamed or unidentified, which, according to the critics, might have 
led the unwary investigators to an opposite conclusion had the factors been prop- 
erly recognized. Investigators, anticipating such criticism, sometimes feel com- 
pelled to invoke excessively elaborate (and possibly inappropriate) models, or the 
latest in sophisticated software, to control large numbers of variables, sacrificing 
interpretability of results in the process. 
In this article I tackle the question of just how bad confounding is, using case 
studies drawn from two major problem areas: the relation of artificial sweetener 
use to bladder cancer, and the relation of cervical dysplasia to oral contraceptive 
use. Both are examples of weak associations. There are over a dozen studies in 
each area from which to draw illustrative material, and there is reasonable con- 
sensus among epidemiologists about what the “right” answer is. Furthermore, 
recent reviews have been published for both (32, 40). 
The two problem areas complement each other, since the subjects are drawn 
from greatly different age groups (bladder cancer cases are far older) and social 
strata (cervical dysplasia is more prevalent among those of lower socioeconomic 
r From the Workshop on Guidelines to the Epidemiology of Weak Associations, American Health 
Foundation, New York, December 4-5, 1985. 
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status). Spurious associations, if any, which could masquerade as confounding 
are related to different factors in the two examples. 
STUDIES OF ARTIFICIAL SWEETENER USE AND BLADDER CANCER 
In 1985 a National Academy of Sciences committee evaluated the carcinoge- 
nicity of cyclamate (32), which, together with saccharin, was used as an artificial 
sweetener (AS) in sugar substitutes, diet beverages, and diet foods. Table 1 shows 
the relative risk (RR) estimates, by sex, with confidence intervals. In 8 of the 10 
studies, the RRs are very close to 1.0. Two studies (13, 27) found RRs signifi- 
cantly higher than 1.0, but for different sexes. While all were case-control 
studies, they were done in three different countries, involved exposures over dif- 
ferent time periods, used different methods to assess exposure, differed greatly in 
selection of controls, and covered populations with vastly different distributions 
of confounding variables, such as smoking, occupation, and residence. 
Study 1: Howe et al., 1977 (13); Miller and Howe, 1977 (24); Howe et al., 
1980 (14) 
Howe and co-workers conducted a population-based case-control study in 
three provinces of Canada. Cases consisted of 480 men and 152 women with 
bladder cancer. Controls were individually matched to cases on sex, age, and 
TABLE 1 
RELATIVE RISK FOR BLADDER CANCER AMONG ARTIFICIAL SWEETENER EVER-USERS 
Study 
No. exposed/total no. Significance or 
Relative 95% confidence 
Sex Cases Controls risk interval 
Morgan and Jain, M 30/158 30/158 1.0 NS 
1974 (28) F 13174 28174 0.4 P< 0.01 
Wynder and Goldsmith, M 131132 161124 0.7 NG 
1977 (46) F 413 1 5129 0.7 NG 
Howe et al., M 731480 471480 1.6 P = 0.009 
1977 (13) F 18/152 30/l 52 0.6 NS 
Kessler and Clark, M 29136.5 1261365 1.1 NS 
1978 (15) F 791154 761154 0.8 NS 
Morrison and Buring, M NG NG 0.8 0.6-1.1 
1980 (30) F NG NG 1.6 0.9-2.7 
Hoover and Strasser, M 90912258 172313977 1.0 0.9-1.1 
1980 (12) F 3841742 73211499 1.1 0.9-1.3 
Wynder and Stellman, M 761302 771299 0.9 0.7-1.3 
1980 (47) F 14165 19/65 0.6 0.3-1.4 
Najem eE al., 
1982 (31) Both 12174 191142 1.3 0.6-2.8 
Moller-Jensen er al., M 551284 1501583 0.7 0.5-1.0 
1983 (25) F 26196 50/193 1.1 0.6-1.9 
Mommsen ef al., M NG NG NS NG 
1982, 1983 (26, 27) F 6147 2197 6.7 1.5-30.2 
Note. NS = not significant; NG = not given. 
Source. Ref. (32). 0 1985, by the National Academy of Sciences. Reprinted with permission. 
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neighborhood of residence. The exposure of interest was current or past use of 
sugar substitutes. 
Potential confounding variables included education, occupational exposures, 
history of bladder or kidney diseases, kidney infection, smoking, instant and reg- 
ular coffee use, and use of nonpublic water supply. Most of these variables were 
controlled at two levels. RRs were estimated by the methods of Miettinen (20) 
and of Pike er al. (35) for matched pairs; for those analyses in which the matching 
had to be broken because of small numbers of subjects, the Mantel-Haenszel 
procedure was used (17). 
The finding of an RR of 1.6 in men, when first published in 1977, was at odds 
with all other human studies published to date, though not with three high-dose 
studies on rats which triggered a proposal to ban saccharin by the Food and Drug 
Administration (8). The RR cited was based on the standard matched-group 
method, using the ratio of discordant pairs. Through study design, the variables 
sex, age, race, and neighborhood of residence were matched, and therefore could 
not confound. Even when the matching was broken for subsequent analyses, the 
underlying distributions of those four variables were practically identical in cases 
and controls. 
There are, of course, many other “potentially confounding” variables, some 
socioeconomic and others having to do with personal health history and lifestyle 
habits. Education, occupation, history of bladder and kidney infections, use of 
nonpublic water supply, smoking, and instant coffee use were controlled based on 
the observation that they were distributed differently among cases and controls. 
These adjustments had an inconsequential influence on the basic RR of 1.6. 
The Howe study was published in the September 17, 1977, issue of Lancet. The 
same issue carried an editorial highly critical of the findings, citing, in particular, 
“potentially important confounding” which might have been introduced by 
failure to control more closely for smoking and instant coffee use. Replying to 
this criticism, Miller and Howe (24) reported unpaired RRs in individual strata of 
smoking and instant coffee consumption, shown here in Table 2. 
The authors cited these RRs as evidence that neither exposure confounds the 
association with AS use. For coffee, that conclusion is certainly true, since this 
control results in practically no RR change. The situation is less clear with 
smoking, which shows that the elevated RR comes mainly from strata of heavy 
current or former smokers. This is difficult to explain. I favor the view that the 
result in ex-smokers is a manifestation of body weight: ex-smokers tend to gain 
weight (or to believe they do), and consume AS because of it, as other studies 
show AS use to be positively correlated with weight (37). 
Cases and controls were similar in a very large number of other variables which 
were not matched by design: marital status; religion; years of residence in the 
province; consumption of milk, tea, fiddlehead greens, meats containing nitrates, 
nitrites; history of asthma, tuberculosis, nonbladder operations; illnesses other 
than urinary infections; use of analgesics; and cooperation and interest in the 
interview. Therefore, none of these variables, or numerous other unmeasured 
variables related to them, are likely to have been confounders. 
Several years after their two initial publications, Howe and colleagues pub- 
lished a more detailed analysis of many bladder cancer risk factors (14), including 
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TABLE 2 
RELATIVERISKFORBLADDERCANCERINARTIFICIALSWEETENERUSERS WITHLNSTRATAOF 
INSTANT COFFEE AND CIGARETTE CONSUMPTION 
RR 
Current instant coffee use 
None 
Less than 1.5 cups per day 




Ex-smoker, under 5,000 packs 
Ex-smoker, at least 5,000 packs 
Current smoker, under 15 cigarettes/day 











1.7 (P = 0.01) 
Source. Ref. (24). Reprinted with permission. 
AS. Whereas their original analyses used simple Mantel-Haenszel style 
methods, this later paper contained elaborate sets of linear logistic models, al- 
lowing control for many extraneous factors, including those listed above that 
were deemed unlikely to confound anyway. Table 3 presents the models used and 
the RRs for AS consumption, first as a continuous variable (frequency per day) 
and then in four categories of dosage. 
The RRs given in the final column of Table 3, for Model 4, reflect, though 
weakly, the dose-response relationship reported in the original article. In this 
analysis, 10 variables were controlled, and the RR at the highest dosage was 2.8 
(P = 0.08). It would be interesting to examine what influence control for those 10 
potential confounders had on these RR estimates; fortunately, these values were 
reported by Howe ef al.: 1.2, 1.8, 1.4, and 2.8, respectively. At the highest 
dosage, P = 0.02. The authors reasonably concluded that, whatever other biases 
may have been present, their reported RRs, whether obtained by stratified anal- 
ysis or obtained by logistic regression, were not tainted by unidentified con- 
founding, as the editorial in Lancet had alleged. 
No explanation has been posed for why this study differs from the majority of 
others in its finding of a significant elevation of risk among men. Chance is one 
possibility, and some unidentified bias is another. However, confounding is nut a 
likely explanation. The results of the further analyses by Howe and colleagues 
demonstrate the futility of blaming an unusual or undesired result on unspecified 
confounding. 
Study 2: Hoover and Strasser, 1980 (12) 
This is the largest of all the AS studies reviewed. In fact, it is the largest 
epidemiologic bladder cancer study ever undertaken. It was designed as a case- 
control, population-based study, with interviews done in the patients’ and con- 
trols’ homes. The population base was the National Cancer Institute’s Surveil- 
lance, Epidemiology, and End Results (SEER) program, along with the New 
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TABLE 3 
LOGISTICREGRESSION-DERIVEDRELATIVERISKSFORBLADDERCANCERAMONGMALESIN 










Heavy inhalation of pipe smoke 
Employment in high-risk industry 
Exposure to dust or fumes in 
high-risk industry 
Use of nonpublic water supply 
History of bladder infection 
History of diabetes 
No. grades of school 
Aspirin: lifetime use--tablets 
Aspirin: 3 dosage categories 
Coffee: cups per day 
Coffee: 3 dosage categories 
Instant coffee: 3 dosage categories 
Regular coffee: 3 dosage categories 
Artificial sweetener 
Avg frequency per day 
0.1-4 per day 
5-6 per day 
7-8 per day 














Source: Ref. (14). 
Jersey Cancer Registry, which together covered about one-tenth of the popula- 
tion of the United States. There were 2,258 male and 752 female bladder cancer 
cases. 
The comparison group consisted of 4,337 males and 1,446 females drawn from 
an age- and sex-stratified random sample of the general population in the SEER 
areas, frequency-matched 2:l to cases. To evaluate exposure, a detailed history 
of AS use in tabletop sweeteners, diet beverages, and diet foods was obtained 
from each subject during the interview. 
Among the dozen or more confounding variables considered were age, sex, 
race, geographical region, smoking, coffee consumption, occupational exposure 
to chemicals (dye, leather, rubber, ink, paint), history of diabetes, education, 
obesity, use of hair dyes, and history of urinary infections. The principal statis- 
tical methods used were the stratified analyses of Gart (10) and Mantel- 
Haenszel, and the Mantel extension test for dose-response (16). The study pre- 
sented results with Mantel-Haenszel adjustments for age, race, cigarette 
smoking, coffee drinking, and occupational exposures, or subsets of these vari- 
ables. 
The main findings of this study were absence of elevated RR in the group as a 
whole, but positive associations with AS use in certain otherwise low-risk sub- 
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groups. Many RR tables were given for groups satisfying various restrictions, 
such as for male heavy smokers and female nonsmokers who were also not occu- 
pationally exposed to known bladder carcinogens. While comparable RRs 
without adjustment for confounding were not presented, Hoover and Strasser 
stated explicitly that the adjusted RRs were not different from those crude esti- 
mates. 
Study 2A: Walker et al., 1982 (43). A private organization, Epidemiology Re- 
sources, Inc., undertook a reanalysis of the Hoover-Strasser data, which were 
obtained under the Freedom of Information Act. The novel feature of this anal- 
ysis is the concept of the risk score, a multivariate function which combines the 
effects of several risk factors through a logistic regression method. This tech- 
nique, developed by Prentice and Pyke (36), is distantly related to the “con- 
founder score” discriminant method proposed by Miettinen (23), and shares the 
conceptual feature of condensing information from many extraneous factors into 
a single variable. 
The variables upon which the risk score was based were cigarette smoking (five 
levels), coffee consumption (four levels), history of bladder infection (yes/no), 
occupational exposure to known bladder carcinogens (yes/no), and education 
(two levels). 
Walker’s Table 2 (not reproduced here) enumerates the RRs for three different 
dosage measures of nonnutritive sweeteners: duration (five levels), amount (five 
levels), and cumulative dosage (six levels). At each of these 16 dosages the RR 
estimate was given three ways: crude, adjusted for the four study design variables 
(region, age, sex, race), and adjusted for those four variables plus five others: 
cigarette smoking, education, history of bladder infection, coffee consumption, 
and job exposure. At 13 of the 16 dosages the RRs were identical no matter how 
much adjustment was done; in the other three, the RR changed by 0.1 unit. 
Walker et al. also presented the data from Hoover’s analysis of low-risk white 
females, which was adjusted for age and restricted to nonsmokers not occupa- 
tionally exposed to known bladder carcinogens. They further adjusted these data 
for geographical region, with results as shown in Table 4. 
It can be seen from Table 4 that the shifts in RR are minor and fall within the 
published confidence intervals. Disagreement between the two teams of investi- 
gators centered around legitimacy of the risk score method itself [see Ref. (1 l)] 
and use of subgroup analysis. Confounding or potential confounding was scarcely 
mentioned, nor was there any reason for it to be; confounding was a negligible 
factor in this study. 
Study 3: Morrison and Buring, 1980 (30) 
The third artificial sweetener study which contains useful information on con- 
founding is that of Morrison and Buring. It was also a case-control, population- 
based study, comprising cases of lower urinary tract cancer (mainly bladder 
cancer, but including cancers of the renal pelvis, ureter, and urethra). The sex 
distribution of the 592 cases was not given. 
The comparison group was drawn from a random sample taken from resident 
lists of the Boston standard metropolitan statistical area (SMSA) towns from 
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TABLE 4 
RELATIVE RISK FOR BLADDER CANCER WITH VARIOUS ADJUSTMENTS USING THE RISK 
SCORE METHOD 
Relative risk, adjusted for 
Category of artificial 
sweetener use 






3 or more 
2 or <5 more, years 
5-9 years 

























Source. Ref. (43). Reprinted with permission of American Journal of Public Health and Epidemi- 
ology Resources, Inc. 
which the cases came, matched for age and sex, though not town. The exposure 
questions included a detailed history of consumption of specific sugar substitutes 
and diet beverages. 
The seven potential confounding variables considered were age (under 65, 
65-74, 75 and over), sex, smoking history, high-risk occupation or occupational 
exposure to known bladder carcinogens, age at leaving school, marital status, and 
religion. The principal statistical methods used were the RR calculations of Gart 
(10) and Miettinen (21), adjusting for age, sex, and smoking. Further stratification 
was done for occupation; and a subsidiary logistic regression analysis was done to 
control the remaining variables. 
The RR estimates according to the level of control for combinations of con- 
founders are presented in Table 5. It is evident that confounding played no dis- 
cernible role in influencing the results of this study. 
Study 4: Wynder and Stellman, 1980 (47) 
As our final AS example, we consider the two studies of Wynder and Stellman. 
The published portion is a hospital-based, case-control study, with 302 male and 
65 female bladder cancer cases. The comparison group consisted of other hospi- 
talized patients without a diagnosis of a tobacco-related disease, individually 
matched from the control pool, on age, sex, hospital, and hospital room status 
(private, semiprivate, ward). Exposure was consumption of sugar substitutes and 
diet beverages. The 10 confounding variables considered included the four 
matching variables mentioned above, history of diabetes, occupation, obesity, 
religion, consumption of coffee and tea, and smoking history. RR estimates were 
made via the Miettinen matched-pair method (20), and t tests were used to com- 
pare means of AS consumption variables. The results were completely consistent 
with at least eight other studies [shown in Table 1 and summarized by the NASi 
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TABLE 5 
RELATIVERISK(AND 95% CONFIDENCEINTERVALS)FORBLADDERCANCERINARTIFICIAL 
SWEETENERUSERS, ADJUSTEDFORDIFFERENT VARIABLES 
Men Women 
“Exposure” Adjusted for RR 95% C.I. RR 95% (2.1. 
Diet drinks Age 0.8 0.6-1.1 1.6 0.9-2.7 
Age, smoking 0.9 0.7-1.2 1.8 1.0-3.3 
All variables (L.R.) 0.7 Not given Not given 
Sugar substitute As 0.8 0.5-1.1 1.5 0.9-2.6 
Age, smoking 0.9 0.6-1.3 1.9 1.0-3.6 
All variables (L.R.) 0.8 Not given Not given 
Source. Ref. (30). Reprinted with permission of The New England Journal of Medicine. L.R., lo- 
gistic regression. 
NRC Committee on Carcinogenicity of Cyclamate (32)]. Adjustment for the many 
variables noted above had no appreciable effect on risk estimates in this popula- 
tion. 
A far more interesting and illustrative aspect of this project came out of a pre- 
liminary phase which has never been formally published. Case-control studies of 
tobacco-related cancers, including bladder cancer, have been conducted by the 
American Health Foundation since its founding in 1968. Every few years, data 
bases are consolidated and analyzed together. The study reported above was 
based on data collected from 1977 to 1979. However, a limited number of ques- 
tions concerning AS usage had been introduced into an earlier version of the 
questionnaire, in 1974. Interim analyses yielded provocative results which the 
authors were reluctant to publish without further confirmation. Some of these 
results, however, were included in a progress report to the funding agency, the 






Variables adjusted Relative 
(Mantel-Haenszel) risk 95% C.I. 
Males (N = 402) None 1.85 1.45-2.36 
Age, hospital, 
hospital room status, 
year of interview 1.43 1.10-1.86 
Above plus education 1.13 0.60-2.09 
Females (N = 122) None 0.99 0.61-1.59 
Age, hospital, 
hospital room status, 
year of interview 0.89 0.48- 1.64 
Above plus education 0.80 0.20-2.98 
Source. Ref. (47). Copyright 1980 by the AAAS. Reprinted with permission. 
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The adjustment cited in Table 6 brings the final RR estimates closer into line 
with those of the article published on the subsequent series. It is the only illustra- 
tion available from AS studies of a bona tide case of identifiable confounding, for 
which appropriate adjustment through stratification removed the spurious effect. 
Furthermore, the authors recognized the artifactual nature of the elevated RR in 
men, and chose not to publish the results. Bross (5) proposed alternatively that 
the unpublished odds ratios represented the true “effect” of AS, but the authors 
have maintained their original position. 
There is little doubt that confounding is at the core of these results. Where did 
it come from? Probably, it arose from “oversampling” from hospitals with pa- 
tients of lower socioeconomic status (SES). Quotation marks are used because, 
in fact, sampling was done properly from the viewpoint of lung cancer, numeri- 
cally the largest rubric in a study that included cancers of the lung, larynx, 
mouth, esophagus, and bladder. Bladder cancer in men occurs in higher socioeco- 
nomic strata than does lung cancer, so that if controls are drawn from the same 
hospitals as the cases cited above, they will tend to have the same (lower) SES to 
match the lung cancer cases. As SES was also a strong correlate of AS use, the 
controls in the first study thereby had lower levels of AS consumption, artificially 
raising the RR. 
To correct this problem, the second study was begun afresh with rigorous one- 
to-one matching (rather than pool or frequency matching), on four variables, one 
of which was a socioeconomic indicator: hospital room status. When the time 
came for analysis, all bladder cancer cases, along with their specifically matched 
controls, were sequestered in a separate computer file, so that the SES distribu- 
tion was automatically identical for cases and controls. The result was the same 
as what could be anticipated if a substantial number of high-SES controls had 
been included in the first study, and stratification was done on the basis of SES. 
In the second study, the number of controls was substantially smaller (and the 
relative study cost much lower). 
In summary, the four AS studies considered in depth here are consistent with 
one another. Despite a wide variety of techniques for controlling confounding 
variables, and many differences in distributions of those variables in the under- 
lying populations, control for confounding had very little effect on, and probably 
was not an important feature of, any published study. Confounding was important 
in a preliminary segment of one study which, in fact, was not published precisely 
because of this concern. The source of confounding was identified and eliminated 
by design, not analysis, in a subsequent study phase. 
CERVICAL DYSPLASIA AND ORAL CONTRACEPTIVES 
Numerous studies have been made of the possible influence of steroid contra- 
ceptive (birth control pill) use on neoplastic processes in the cervix uteri. I have 
used the vague term neoplastic processes deliberately, because the ambiguity of 
outcome is part of the analytical problem. Even though invasive cervical carci- 
noma is, theoretically, a possible result from pill use, its incidence is so low that 
few cases are available for study. The high rate of surveillance in the United 
States and the United Kingdom is at once a factor in the low rate of carcinoma as 
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well as a serious biasing factor in assembling populations for study. Most investi- 
gators have elected to study, as a proxy outcome, various degrees of cervical 
dysplasia, based on the widely held belief that this condition is a necessary stage 
in the pathological development of cancer (38). 
Table 7 presents a summary of the overall RRs for each of the studies reviewed 
by Swan and Petitti (40), some of which are considered in detail in this article. 
With regard to confounding, the most obvious feature of these studies is the much 
larger number of variables initially singled out as potentially troublesome and 
worthy of statistical control. This is an indication that, even in the earliest of 
these works, investigators were building on a knowledge base in which an under- 
standing of the importance of the potential for confounding by these factors ex- 
isted, in contrast to the AS studies, in which the relation of other variables to AS 
usage usually had to be determined anew at the start of each study (29). 
Study 5: Thomas, 1972 (41) 




Melamed et al., 
1969 (19) 
Thomas, 1972 (41) 
Worth and Boyes, 
1972 (44) 
Boyce et al., 
1972, 1977 (1, 2) 
Meisels et al., 
1977 (18) 
Stern et al., 
1977 (38) 
Ory et al., 
1977 (33) 
Peritz et al., 
1977 (34) 
Wright et al., 
1978 (45) 
Swan and Brown, 
1981 (39) 
Clarke et al., 
1985 (6) 
No. cases 
207 CIS and 
invasive 
324 Pap classes 
III, IV, v  
310 CIS 







3 1 dysplasia 
39 CIS and 
invasive, 
26 dysplasia 




Ever OC users vs 
diaphragm users 
Ever OC users vs 
all other methods 
Ever OC users vs 
all other methods 
Ever OC users vs 
all other methods 
Ever OC users vs 
all other methods 
Progression of dysplasia 
to CIS in new users 
vs all other methods 
Ever OC users vs 
IUD users 
Ever OC users vs 
other methods 
Ever OC users vs 
IUD users vs 
diaphragm users 
Ever OC users vs 
all other methods 















Note. CIS = Carcinoma in situ. 
Source. Ref. (40). Reprinted with permission. 
a Prevalent cases. 
b Incident cases. 
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lished by Thomas. It was a case-control study based on the outcome of Pap 
smears from 324 women ages 15-50, which fell into classes III, IV, or V. The 
exposure consisted of the type of oral contraceptive (OC), number of months of 
use, and cumulative dose. 
The comparison group consisted of 360 women randomly drawn from those in 
the same Maryland county who had at least one smear during 1965-1969. Thir- 
teen variables were considered as potentially confounding. All were considered 
as binary or yes/no variables: age 30 + , husband circumcised, barrier contracep- 
tives, smoker, attend church weekly, trichomonads on smear, history of vaginal 
discharge, high school education, marital instability, any husband previously 
married, three or more live births, child conceived before marriage, first preg- 
nancy before age 20. 
The statistical method was as follows: first the 2 x 2 association between OC 
use and each of the 13 above variables was displayed in cases and controls sepa- 
rately, and significant differences were noted. OC users differed significantly 
from nonusers in both cases and controls only with respect to two variables: age 
and first pregnancy before age 20. 
Unadjusted RRs were then computed using the method of Cornfield (7), fol- 
lowed by adjustment using an unspecified direct method for each of the 13 con- 
founders, one at a time. Finally, a multiple regression technique attributed to 
Feldstein (9) was used to adjust for all 13 simultaneously. 
Thomas’s Table 6 (not reproduced here) gives the RRs for four categories of 
outcome [carcinoma in situ (CIS), dysplasia, no biopsy, and total cases] adjusted 
for each variable separately, and adjusted for none and for all simultaneously. The 
RR of 0.78 for CIS fell to 0.58 after adjustment for all 13 variables; the RR for all 
cases went from 1.09 to 0.91. Adjustment for individual variables pushed the RR 
up or down a little, but the multivariate adjustment produced the farthest excur- 
sion. For all four outcomes, adjustment lowered the RR, reinforcing the conclu- 
sion that OC use did not increase risk for cervical carcinoma or its pathologic 
precursors. 
Study 6: Peritz, et al., 1977 (34) 
The Kaiser-Permanente Walnut Creek group reported a positive association 
between cervical carcinoma incidence and total duration of OC use. The results 
were based on 31 cases of dysplasia and 35 cases of CIS observed in a sample of 
17,942 women, mostly ages 20-54 years, followed prospectively. The comparison 
population consisted of nonusers enrolled in the same health plan as the users. 
Adjustment was made for eight confounding variables, measured at entry into 
the study (with the number of levels): age (4), education (3), marital status (2), 
number of Pap smears (2), religion (2), number of pregnancies (2), smoking (2), 
history of certain infections (2). 
Instead of the traditional statistical methods, two new methods were proposed 
and used, each involving a rank-order z statistic; no reason was given for avoiding 
standard prospective methods. Both procedures involve classifying women into 
like strata based on similar values of the confounding variables, making this, in 
principle, a variant matched-group method. RRs were calculated at each duration 
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level, but trend analysis was not performed. Distributions of the confounders in 
cases and noncases was presented [Table 2, Ref. (34)], so that stratum-specific 
RRs could be calculated. 
The effect of adjustment for age and other variables is given in Table 8. (The RR 
here is assumed for CIS; the source table in Peritz et al. is not clearly labeled.) 
Although comparison between tables is hindered by an unexplained shift in 
duration categories, the changes in RR brought about by adjustment for different 
numbers of variables is trivial. There is no practical difference between the 4+ 
years RRs shown in Table 8, and any standard analysis would have concluded- 
as these authors did-that an effect exists. The interpretation and generalization 
of results depends more on consideration of questions of bias than of con- 
founding, especially since there seems to be some uncertainty as to the exclusion 
of women with hysterectomies from the population, which would certainly affect 
risk estimates. 
Study 7: Wright et al., 1978 (45) 
In a study in the United Kingdom, 17,032 white married women, ages 25-39, 
attending family planning clinics were followed prospectively from 1968 through 
1977. The purpose of the study was to investigate the reduced risk among dia- 
phragm users, rather than increased risk among OC users, as was the case with 
other studies considered here. A supplemental case-control substudy was done 
within the cohort to examine in greater detail (and with greater efficiency) a sub- 
group of subjects who agreed to give intensive interviews, which included infor- 
mation about sexual activity not available from routine records for the other sub- 
jects. 
The comparison group for the cohort study consisted of women who used ei- 
ther the IUD or diaphragm for contraception. Five confounding variables were 
considered (with the number of levels): age (4), social class (3), smoking (3), age 
first married (4), age first pregnant (5). For the case-control study, age at first 
coitus (4) and number of partners (2) were added. 
In the cohort study, 26 dysplasias, 33 CIS, and 6 cases of invasive carcinoma 
were observed. The statistical method consisted of comparison of incidence rates 
TABLE 8 
RELATIVE RISK FOR CARCINOMA in Sizu AMONG ORAL CONTRACEPTIVE (OC) USERS ACCORDING TO 
YEARS OF USAGE 
Duration of OC use 
RR 0 To 1 year l-4 years 4+ years 
Crude 
Age-adjusted 
1.0 1.4 1.8 4.2 
1.0 2.0 3.0 5.4 
0 To 2 years 2-4 years 4+ years 
5 variables controlled 1.0 2.0 1.8 4.0 
8 variables controlled 1.0 2.2 2.0 5.1 
Source. Ref. (34). Reprinted with permission. 
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between levels of confounders one at a time, using a chi-square test, and an un- 
named trend test [probably Mantel (16)]. Smoking and age first married were 
significantly associated with incidence. 
Incidence rates were given at each level of each confounder, taken one at a 
time, with chi-square tests for trend. In addition, an indirect method (42) was 
used to adjust for the five other factors, with the results shown in Table 9. Despite 
large intercorrelations between variables, adjustment made very little difference 
in rates. 
In the case-control study, 52 cases and 139 controls were matched by age and 
clinic. RRs were estimated for combinations of exposure and confounders using 
logistic regression of Breslow et al. (3). Values of the estimated RR for cervical 
neoplasia in diaphragm users, relative to users of other methods, are given for 
various combinations of confounders in Table 10. The crude RR of 0.13 increased 
to 0.23 when smoking, age at first intercourse, and number of partners were 
added to the model (Table 10). Significant values in the last column of the table 
identify two important risk factors in their own right: cigarette smoking and 
number of partners. Age at first intercourse is the most important confounder, 
since it confers the greatest increase on the crude RR, but once it is absorbed into 
the model, its influence on the association between diaphragm use and cervical 
neoplasia is not significant. 
Study 8: Swan and Brown, 1981 (39) 
This second offering from the Walnut Creek group is a case-control study of 
CIS or severe dysplasia in relation to OC use and sexual activity. The study group 
consisted of 26 prevalent plus 43 incident cases. The exposure variable was 
“years of OC use.” 
The comparison group consisted of three controls per case, matched on age, 
study entry date, number of Pap smears at entry, marital status, religion, educa- 
tion, parity, and year of menopause. Besides the eight matching variables, six 
other potential confounders considered were age first married, age first pregnant, 
age regular coitus, number of sexual partners, contraceptive method, and history 
of certain infections. 
The statistical method consisted first of displaying mean values of confounding 
variables for cases and matched controls separately for prevalent and incident 
cases. An RR analysis was done with the Miettinen confounder score method 
(23). A sexuality index, comprising a linear combination of sexual activity vari- 
ables, was plotted in cases vs controls. The RR was 1.7 for incident cases and 0.6 
TABLE 9 
INCIDENCEPER 1,000 WOMAN-YEARSOF~BSERVATION 
Crude Adjusted 
Oral contraceptives 0.95 0.91 
Diaphragm 0.17 0.19 
IUD 0.87 0.93 
Source. Ref. (45). Reprinted with permission. 
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TABLE 10 
RELATIVE RISK AND CHI-SQUARE FOR CERVICAL NEOPLASIA IN DIAPHRAGM USERS, RELATIVE TO 
NONUSERS, ADJUSTING FOR A NUMBER OF VARIABLES 
Model RR Chi-square 
C.M. alone 0.13 12.96*** 
C.M. plus social class 0.13 12.63*** 
CM. plus cigarette smoking 0.14 10.13** 
C.M. plus age first marriage 0.15 9.64** 
C.M. plus age first pregnant 0.14 10.4l3** 
C.M. plus age first intercourse 0.19 6.11” 
C.M. plus number of partners 0.15 9.30** 
CM. plus cigarette smoking, 
age first intercourse, 
number of partners 0.23 4.33* 
* P < 0.05. 
** P < 0.01. 
*** P < 0.001. 
Note. C.M. = contraceptive method. d’ = degrees of freedom. 
Source. Ref. (45). Reprinted with permission. 
Chi-square 




0.72 (2 dfi 
10.34 (2 &J** 
3.55 (3 dyJ 
7.55 (3 df) 
7.01 (3 df) 
11.69 (1 dfi*** 
23.81 (6 dfi*** 
for prevalent cases. A major determinant of this difference was the greater proba- 
bility of screening for OC users compared with that of nonusers, and indeed it is 
this demonstrated ascertainment bias that colors the entire analysis. 
The RR estimates as determined by the confounder score method were pre- 
sented in specific strata of the sexuality index, according to OC use and whether 
prevalent or incident, making 24 cells in all. Unfortunately, small numbers of 
subjects made comparisons difficult. The authors’ conclusion was that “adjusting 
for sexual factors explains some, but not all, of the relative risk attributable to OC 
use.” That is, consideration of those factors removed some, but not all, of the 
confounding. 
This study is the most innovative, aggressive, and perhaps successful in at- 
tempting to account for the confounding influence of sexual variables. The 
method still lacks true multivariate control (as one would obtain with logistic 
regression), because the Miettinen method and use of the linear combination 
sexual index attempt to condense multidimensional information onto a single 
axis. The small sample size makes firmer conclusions difficult. 
Study 9: Clarke et al., 1985 (6) 
This Canadian case-control study was designed to Investigate the relationship 
between cervical dysplasia and the risk factors OC use, sexual behavior, and 
cigarette smoking. There were 250 cases of biopsy-confirmed dysplasia (CIS ex- 
cluded). Duration of OC use was the main exposure under study. Considered as 
confounding variables were (with the number of levels) education (2), number of 
sexual partners (3), age at first coitus (2), smoking (3), and number of cigarettes 
smoked per day (3). 
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The comparison group consisted of 500 neighborhood controls matched on age, 
presence of a uterus, neighborhood of residence, and whether they lived in a 
house or an apartment. 
The statistical method consisted of computing an unmatched RR using the 
Miettinen odds ratio (22) for confounders considered one at a time. In addition, a 
matched logistic regression analysis was done (4). The overall RRs for cervical 
dysplasia with respect to OC use were 3.0 (Miettinen) or 2.6 (logistic regression). 
Table 11 presents the crude RRs in relation to each of the variables, along with 
the results of adjustment using logistic regression. When confounders were added 
to the logistic regression model (which always included OC use), their associated 
RRs were nearly identical to the crude RRs without OC use, with the following 
important exceptions: the crude RR for 6 or more sexual partners (relative to one 
partner) rose from 5.1 to 6.9 after OC use (ever vs never) was added to the model; 
and the RR for OC use fell from 3.0 to 1.7 when number of sexual partners was 
taken into account. 
The latter observation, that the OC RR lost its statistical significance after ad- 
justment for sexual partners, was taken by the authors as an indication that OC 
use itself was probably not a true causal factor. This conclusion might be correct, 
but it is equally likely, based on these data, that the residual risk (1.7) is a true 
one. The small number of cases reduces the statistical power (P = 0.14), and the 
TABLE 11 
RELATIVE RISK FOR CERVICAL DYSPLASIA IN ORAL CONTRACEITIVE USERS, COMPARED WITH 
NONUSERS, ADJUSTED FOR DIFFERENT VARIABLES 
Logistic regression 
Variable 
Crude RR Adjusted 
(matched data) for RR 
Number of sexual partners 
1 
2-5 
6 or more 
Age first intercourse 
Under 18 
18 or older 














OC use 2.8** 
1.0 
3.2** 










Age first intercourse 





** P < 0.01. 
Source. Ref. (6). Reprinted with permission. 
aP = 0.14. 
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ultimate RR level is more in line with that found in the majority of cervical dys- 
plasia studies considered in this article. Nevertheless, this is the most clear-cut 
case of true confounding observed in the entire spectrum of studies. 
SUMMARY 
Two examples of weak associations have been explored in which a large 
number of studies have been done: artificial sweeteners in relation to bladder 
cancer, and oral contraceptives in relation to cervical dysplasia. The consensus 
among epidemiologists that has developed in each example area is remarkable, 
because it is based on a wide variety of study designs, populations, analytic tech- 
niques, and choice of confounding variables. Even those studies that differ in 
individual respects from the others (6, 13) can be viewed as mostly consistent 
with the consensus with respect to magnitude of effects. 
It is unlikely that the overall judgment of investigators, as summarized by ex- 
tensive reviews (32, 40), is incorrect; if there are inadvertent inaccuracies due to 
misunderstanding of data, it is extremely unlikely that they are due to failure to 
take confounding into account. The unresolved issues in the great majority of 
these studies have to do with bias and selection factors. 
The most serious potential mistakes that might be made based on erroneous 
interpretation of these and similar types of data would have to do with regulating 
the products involved, which here involve a prescription drug (OC) and a con- 
sumer product (AS). The decision-making process, at least for drug regulation, 
involves weighing of risks and benefits. To the extent that these studies have 
placed reasonable confidence limits about the risks, they have contributed to the 
knowledge base for making those decisions, even though the associations are 
“weak.” 
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